悦康药业：拟发行H股

Core Viewpoint - Yuyuan Pharmaceutical (688658.SH) plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitive edge and international brand image while diversifying financing channels [1] Group 1: Company Strategy - The company aims to improve its overall competitiveness and better utilize international capital markets [1] - The issuance of H-shares is part of a strategy to enhance the company's international brand image [1] Group 2: Regulatory Compliance - The company will comply with relevant laws and regulations, including the Company Law, Securities Law, and the Management Measures for the Overseas Issuance of Securities and Listing by Domestic Enterprises [1] - The listing will adhere to the rules of the Hong Kong Stock Exchange [1] Group 3: Shareholder Consideration - The company will consider the interests of existing shareholders when determining the timing and window for the H-share issuance [1] - The decision will be valid for 24 months from the date of the shareholders' meeting resolution, with the possibility of extension [1]